Symrise invests in Synergio
Symrise has made an unspecified investment to take a minority stake in Israeli biotech Synergio, with the option of owning a majority in future. Financial terms are not being disclosed.
Based in Jerusalem, Synergio specialises in developing natural antimicrobial combinations from plants for product protection, using a data-driven, biochemistry-based, computational platform. Symrise is already a major player in this field within the personal care sector and sees growth opportunities in working together with Synergio.
“Synergio’s bioactives fit seamlessly into our Product Protection portfolio, said Dr Joern Andreas, president scent and care at Symrise. “The partnership will accelerate the development of broad-spectrum antimicrobial solutions.”